Search
for
Sort by
Research 61–90 of 1000+
- 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA
- Prostate-specific antigen as a diagnostic marker in female hyperandrogenism
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Redefining hormone resistance in prostate cancer
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels
- Effect of ethanol extract of Zapoteca portoricensis stem on liver, kidney and prostatic biomarkers of testosterone-induced benign prostate hyperplasia (BPH) in male albino rats
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation
- Distinct mechanisms for sebaceous gland self-renewal and regeneration provide durability in response to injury
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Prostate cancer and androgenic alopecia
- Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Thrombocytosis Associated with Low-Molecular-Weight Heparin
- Hormonal control of 5.ALPHA.-reductase activity in hamster sebaceous glands.
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Clinical Case Notes. Castleman's disease of the lacrimal gland
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats
- A Natural Product Molecule of Artocarpus Heterophyllus Reverses Inflammation Due to the Effect of Acute Exposure of Prostate Tissue to Testosterone Enanthate in Wistar Rats